April Home Sales Edge Up 0.2% but Miss Forecasts on High Rates

Cover image from cnbc.com, which was analyzed for this article
April home sales disappoint expectations, up slightly but slowed by mortgage rates and economic pressures from Iran war. Spring buying season lurches; first-time buyers sidelined. Forecasts remain cautious.
PoliticalOS
Monday, May 11, 2026 — Business
The housing market remains locked in low volume because elevated mortgage rates continue to outweigh modest inventory gains and slight affordability improvements. Geopolitical costs from the Iran conflict have added further upward pressure on rates without yet producing a sharp sales drop. Buyers and sellers alike are waiting for clearer signals on both borrowing costs and broader economic stability.
What outlets missed
Regional sales differences were not detailed, including a 2.7 percent year-over-year gain in the South. The NAR Housing Affordability Index improved to 110.6 from 101.4 a year earlier, showing concrete relief for buyers. Broader context on how the Iran conflict's energy-price effects compare with prior geopolitical shocks was absent. First-time buyer share and cash transaction percentages appeared in raw NAR data but received little emphasis.
Existing Home Sales Stay Flat as Mortgage Rates and Tight Supply Hinder Buyers
Sales of previously owned homes showed little movement in April, rising a mere 0.2 percent from March to a seasonally adjusted annual rate of 4.02 million units, according to data from the National Association of Realtors. The figure matched the pace from April a year earlier and fell short of economist expectations for growth above 3 percent. Contracts signed in late February and March, when 30-year fixed mortgage rates hovered between 5.98 percent and 6.38 percent, produced the closings counted last month.
The market has now lingered near a 4 million annual pace since 2023, well below the long-term average near 5.2 million. Lawrence Yun, the NAR chief economist, noted that rates remain lower than they were a year ago and that income growth has outpaced price increases in some segments. Yet he added that inventory would need to expand by roughly 30 percent to ease conditions meaningfully. Instead, listings rose only 5.8 percent from March and 1.4 percent from the prior April, leaving a 4.4-month supply that remains below the six-month threshold for a balanced market.
Median home prices continued their climb despite the sluggish volume. The April median reached $417,700, up 0.9 percent from the year before and marking the highest April reading in the NAR series that dates to 1999. Prices have now risen on an annual basis for 34 consecutive months. Days on market lengthened to 32 from 29 a year earlier, suggesting buyers are taking longer to commit amid limited choices and elevated financing costs.
Multiple offers persist in some areas, though they occur with less intensity than during the pandemic surge. Yun pointed to mixed signals in the broader economy, including record stock market levels alongside weak consumer confidence. The housing sector has remained constrained since rates began rising from pandemic lows in 2022, with sales stuck at a 30-year low last year and showing no meaningful rebound through the first four months of this year.
Analysts attribute part of the inventory shortfall to homeowners reluctant to sell and give up low-rate mortgages locked in earlier. At the same time, new construction has not kept pace with household formation in many regions, leaving fewer entry points for buyers. The combination keeps upward pressure on prices even as transaction counts remain depressed.
This spring season has so far produced no visible improvement over last year. With mortgage rates sensitive to broader credit conditions and policy decisions, further relief for buyers would require either lower rates or a sustained increase in available homes. Neither has materialized in sufficient volume to shift the market from its current plateau.
You just read Conservative's take. Want to read what actually happened?
More in Business & Economy

SpaceX IPO Draws $150 Billion in Orders, Twice Oversubscribed
SpaceX's planned IPO drew massive institutional interest with orders exceeding $10 billion.

GSK Buys Nuvalent for $10.6 Billion to Strengthen Lung Cancer Pipeline
GSK agreed to buy US cancer drugmaker Nuvalent for $10.6 billion in its largest-ever acquisition.

Tech Stocks Tumble as Iran-Israel Strikes Renew Rate Fears
Major indexes tumbled with tech and AI stocks hit hardest as Iran-Israel clashes and economic worries mounted. Nasdaq futures later showed signs of rebound.
US Labor Market Stagnates as AI Slows Entry-Level Hiring
The labor market faces stagnation with low hiring and firing rates, while AI is reshaping entry-level roles and prompting companies like Goldman Sachs to adjust hiring plans.